$Eli Lilly(LLY)$ in the end, t

6
Comment
Favorite

$Eli Lilly(LLY)$ in the end, there will only be one winner left. A drug is proven safe and more effective, period. Marketing is also important to attract more consumers and it's doing everything right. It will be the undisputed leader in body weight loss drugs with a large untapped growing market. Leader will take the lion share and be known as the preferred brand.

$Viking Therapeutics(VKTX)$ $Novo-Nordisk A/S(NVO)$

Pick the correct side. DYODD

# Winning Trades

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":471960280339040,"tweetId":"471960280339040","gmtCreate":1756256339582,"gmtModify":1756259149269,"author":{"id":3577070440469601,"idStr":"3577070440469601","authorId":3577070440469601,"authorIdStr":"3577070440469601","name":"TwoDeMoon","avatar":"https://static.tigerbbs.com/f6209e03bb2abcab3856b4485192191c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":13,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.83%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":321,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/8cdf9c7ef4b2919c34da3acc09212083","width":"1086","height":"1653"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/8cdf9c7ef4b2919c34da3acc09212083","width":"1086","height":"1653"}],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$&nbsp;</a><v-v data-views=\"1\"></v-v>in the end, there will only be one winner left. A drug is proven safe and more effective, period. Marketing is also important to attract more consumers and it's doing everything right. It will be the undisputed leader in body weight loss drugs with a large untapped growing market. Leader will take the lion share and be known as the preferred brand.&nbsp;\n \n<a href=\"https://ttm.financial/S/VKTX\">$Viking Therapeutics(VKTX)$&nbsp;</a><v-v data-views=\"0\"></v-v><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp;\n \nPick the correct side. DYODD <img src=\"https://community-static.tradeup.com/news/8cdf9c7ef4b2919c34da3acc09212083\" tg-width=\"1086\" tg-height=\"1653\"></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$&nbsp;</a><v-v data-views=\"1\"></v-v>in the end, there will only be one winner left. A drug is proven safe and more effective, period. Marketing is also important to attract more consumers and it's doing everything right. It will be the undisputed leader in body weight loss drugs with a large untapped growing market. Leader will take the lion share and be known as the preferred brand.&nbsp;\n \n<a href=\"https://ttm.financial/S/VKTX\">$Viking Therapeutics(VKTX)$&nbsp;</a><v-v data-views=\"0\"></v-v><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp;\n \nPick the correct side. DYODD <img src=\"https://community-static.tradeup.com/news/8cdf9c7ef4b2919c34da3acc09212083\" tg-width=\"1086\" tg-height=\"1653\"></body></html>","text":"$Eli Lilly(LLY)$ in the end, there will only be one winner left. A drug is proven safe and more effective, period. Marketing is also important to attract more consumers and it's doing everything right. It will be the undisputed leader in body weight loss drugs with a large untapped growing market. Leader will take the lion share and be known as the preferred brand. $Viking Therapeutics(VKTX)$ $Novo-Nordisk A/S(NVO)$ Pick the correct side. DYODD","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/471960280339040","repostId":0,"isVote":1,"tweetType":1,"viewCount":1811,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["VKTX","LLY","NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":376,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}